World's Best Scientists 2026 revealed!
Jeffrey A. Gelfand

Jeffrey A. Gelfand

D-Index & Metrics

Microbiology

D-Index
51
Citations
11549
World Ranking
4297
National Ranking
1657

Research.com Recognitions

  • 2007 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Jeffrey A. Gelfand is affiliated with Harvard University in the United States. Their research primarily focuses on medicine, with a significant emphasis on infectious diseases, as reflected by 39 publications in this field. Subfields of study include infectious diseases, biomedical engineering, pulmonary and respiratory medicine, molecular biology, and otorhinolaryngology.

The scientist's work is heavily centered around SARS-CoV-2 and COVID-19 research. Key research topics include SARS-CoV-2 detection and testing, COVID-19 clinical research studies, nanoplatforms for cancer theranostics, photodynamic therapy research studies, laser applications in dentistry and medicine, and ocular infections and treatments.

Recent papers authored or co-authored by Jeffrey A. Gelfand include:

  • Evaluation of SARS-CoV-2 serology assays reveals a range of test performance (2020, Nature Biotechnology)
  • Test performance evaluation of SARS-CoV-2 serological assays (2020, bioRxiv (Cold Spring Harbor Laboratory))
  • Rethinking the role of hydroxychloroquine in the treatment of COVID-19 (2020, The FASEB Journal)
  • Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital (2020, The FASEB Journal)
  • High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts (2020, The Journal of Infectious Diseases)

Their frequent co-authors include Mark C. Poznansky, Laísa Bonafim Negri, Tyler E. Miller, Diane Yang, and Michael G. Astudillo. These collaborations highlight a network engaged in diverse areas related to infectious disease research and diagnostics.

Publications by Gelfand have appeared in several key venues, with multiple papers in bioRxiv (Cold Spring Harbor Laboratory), The FASEB Journal, and The Journal of Infectious Diseases. Other publications are noted in Regular and Young Investigator Award Abstracts and Nature Biotechnology.

Jeffrey A. Gelfand has been recognized by the scientific community, having been named a Fellow of the American Association for the Advancement of Science (AAAS) in 2007 and a member of the Association of American Physicians. These honors mark involvement in ongoing professional development and contribution to medical science.

Best Publications

  • Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

    S Okusawa;J A Gelfand;T Ikejima;R J Connolly

  • Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever

    J.G. Cannon;R.G. Tompkins;J.A. Gelfand;H.R. Michie

  • Anticytokine Strategies in the Treatment of the Systemic Inflammatory Response Syndrome

    Charles A. Dinarello;Jeffrey A. Gelfand;Sheldon M. Wolff

  • A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits.

    Go Wakabayashi;Jeffrey A. Gelfand;John F. Burke;Robert C. Thompson

  • Persistent and relapsing babesiosis in immunocompromised patients.

    Peter J. Krause;Benjamin E. Gewurz;Benjamin E. Gewurz;David Hill;Francisco M. Marty

  • Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli.

    G Wakabayashi;J A Gelfand;W K Jung;R J Connolly

  • Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself

    Ralf Schindler;Jeffrey A. Gelfand;Charles A. Dinarello.

  • Test performance evaluation of SARS-CoV-2 serological assays

    Unknown

  • Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor.

    James E. Gadek;Stephen W. Hosea;Jeffrey A. Gelfand;Maria Santaella

  • Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.

    Jeffrey D. Whitman;Joseph Hiatt;Cody T. Mowery;Brian R. Shy

  • A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis.

    T Takabayashi;E Vannier;B D Clark;N H Margolis

  • C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma.

    S Okusawa;C A Dinarello;K B Yancey;S Endres

  • C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro : Comparison with secretion of interleukin-1 beta and interleukin-1 alpha

    S. Okusawa;K.B. Yancey;J.W.M. van der Meer;S. Endres

  • Acquired C1 esterase inhibitor deficiency and angioedema: a review.

    J A Gelfand;G R Boss;C L Conley;R Reinhart

  • Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro

    J. W.M. Van Der Meer;S. Endres;G. Lonnemann;Joseph Gerard Cannon

  • Circulating interleukin-1 beta and tumor necrosis factor-alpha concentrations after burn injury in humans.

    Joseph G. Cannon;Joseph S. Friedberg;Jeffrey A. Gelfand;Ronald G. Tompkins

  • Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event

    Gilles Kaplanski;Reuven Porat;Koichi Aiura;John K. Erban

  • Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment.

    Yang Zeng;Binghao Li;Yingying Liang;Patrick M. Reeves

  • Role of interleukin 1 and tumor necrosis factor on energy metabolism in rabbits

    E. E. Tredget;Yong Ming Yu;S. Zhong;R. Burini

  • Rethinking the role of hydroxychloroquine in the treatment of COVID-19.

    Eric A. Meyerowitz;Augustin G. L. Vannier;Morgan G. N. Friesen;Sara Schoenfeld

  • Hereditary angioedema: The use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery

    Charles J. Jaffe;John P. Atkinson;Jeffrey A. Gelfand;Michael M. Frank

  • Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital.

    Tyler E. Miller;Wilfredo F. Garcia Beltran;Adam Z. Bard;Tasos Gogakos

  • A simple method for the determination of complement receptor-bearing mononuclear cells.

    Jeffrey A. Gelfand;Anthony S. Fauci;Ira Green;Michael M. Frank

  • The immune response to trauma.

    B H Harris;J A Gelfand

Frequent Co-Authors

Mark C. Poznansky
Mark C. Poznansky Harvard University
Charles A. Dinarello
Charles A. Dinarello University of Colorado Anschutz Medical Campus
Michael M. Frank
Michael M. Frank Duke University
Michael R. Hamblin
Michael R. Hamblin University of Johannesburg
Ronald G. Tompkins
Ronald G. Tompkins Harvard University
Go Wakabayashi
Go Wakabayashi Iwate Medical University
Tianhong Dai
Tianhong Dai Harvard University
Sherwood L. Gorbach
Sherwood L. Gorbach Tufts University
Edward T. Ryan
Edward T. Ryan Harvard University
Bradley E. Bernstein
Bradley E. Bernstein Broad Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online healthcare programs can open doors to diverse career options. These programs often provide flexible learning opportunities, making it easier to balance studies with other commitments while gaining essential medical knowledge.

If public health interests you, many institutions offer online MPH programs easy to get into, ideal for those seeking to expand their expertise in epidemiology, disease prevention, and health policy without overwhelming admission processes.

Career pathways extend beyond traditional lab roles. For example, child life specialists play a vital role in healthcare settings by supporting young patients emotionally and psychologically. Understanding how much do child life specialists make can help you evaluate this rewarding career option in the context of your goals.

Finally, it's important to note that higher education opportunities in healthcare are increasingly accessible to a diverse range of students. The best degrees for felons include several online options, highlighting the growing inclusivity and second-chance opportunities within the field.

For a comprehensive overview of available programs, consider exploring various online healthcare programs that align with your interests and career aspirations.

Best Scientists Citing Jeffrey A. Gelfand

Trending Scientists

Recently Published Articles